Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
30 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Xenon Pharmaceuticals Inc. (Xenon) is a biopharmaceutical company which discovers and develops a pipeline of differentiated therapeutics for orphan indications. The company's pipeline products include Glybera, XEN801, sodium channel inhibitor and TV-45070. Xenon through its core platform, Extreme Genetic, discovers various validated drug targets through the study of rare human diseases with extreme traits, including channelopathies, diseases caused by mutations in ion channels. Its platform comprises full complement of in-house capabilities for human genetics, small molecule drug discovery, and for pre-clinical and clinical development.

Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detai

  
Source:
Document ID
GDPH132674D
Country
Industry
Ticker
XENE=CA
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Xenon Pharmaceuticals Inc., Medical Devices Deals, 2010 to YTD 201691
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Xenon Pharmaceuticals Inc., Pharmaceuticals &Healthcare, Deal Details1116
  Partnerships111
    Medpace Enters into Amendment Agreement with Xenon Pharma111
    Xenon Pharma Extends Agreement with Genentech121
    Isis Pharma Enters Into Collaboration With Xenon Pharma132
  Licensing Agreements151
    Xenon Pharma Exercises Option For Licensing Agreement With Isis Pharma For Antisense Drug XEN701152
    Merck Exercises Option For Licensing Agreement With Xenon Pharma For Cardiovascular Disease Targeted Compounds172
    Xenon Pharma Enters Into Licensing Agreement With Teva Pharma For XEN402192
    Xenon Pharma Extends Licensing Agreement with Genentech212
  Equity Offering231
    Xenon Pharma Completes Public Offering of Shares for USD34.5 Million232
    Xenon Pharma Raises USD41.4 Million in IPO of Shares252
Xenon Pharmaceuticals Inc. - Key Competitors271
Key Employees281
Locations And Subsidiaries291
  Head Office291
Appendix301
  Methodology301
  About GlobalData301
  Contact Us301
  Disclaimer301

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Xenon-Pharmaceuticals-Inc-XENE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6662>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Xenon Pharmaceuticals Inc. (XENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Xenon-Pharmaceuticals-Inc-XENE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6662>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research